Rockland Announces General Release of BioQuantiPro™ Host Cell Protein Screening Kit for Bioprocessing

Rockland Immunochemicals, Inc. announced today the general release of their new BioQuantiPro™ CHO-HCP ELISA Kit for detection and screening of host cell protein (HCP) contaminants in bioprocessing.

Written byRockland Immunochemicals Inc.
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Rockland Immunochemicals, Inc. announced today the general release of their new BioQuantiPro™ CHO-HCP ELISA Kit for detection and screening of host cell protein (HCP) contaminants in bioprocessing. The kit was specifically designed with Rockland’s novel, validated antibodies to detect HCP contaminants and to measure analytes from crude cellular harvests, cell culture lysates, and process intermediates. The BioQuantiPro CHO-HCP ELISA Kit boasts the highest coverage of generic CHO-HCP kits, low variability, and, most importantly, the data to back it all up. “While working with bioprocessing clients, we consistently hear the same complaint about HCP kits: ‘The generic kit I am using works OK, but I wish I had reliable data that I can trust for the validation of the antibodies used in the kit’” commented Karin Abarca-Heidemann, PhD., Vice President of Science Operations. “We aimed to create a kit that fills the void by providing transparency into the data necessary to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies